Cardiac Implantable Electronic Device Magnetic Resonance Imaging Registry
NCT ID: NCT02459379
Last Updated: 2017-11-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2016-06-30
2017-04-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Magnetic resonance is the imaging modality of choice for the diagnosis of many diseases of the brain, spinal cord, and musculoskeletal system. For some disease states, no acceptable alternative diagnostic imaging method is available. MRI is not only a superior imaging and diagnostic modality for many disorders, but also does not expose patients to ionizing radiation as does CT. The number of patients living with permanent pacemakers or ICDs is well into the millions (some estimates are up to 4 million in the US), and continues to increase. Likewise, the use of MRI continues to rise annually in all patient groups, however, as people advance in age, they are the most likely to need an MRI scan. As the device population is disproportionally weighted towards the older population, it is exactly this group that has the greatest need for MRI scans, yet may be denied.
As noted in the MagnaSafe information, "To provide optimal care to the increasing number of patients with an implanted cardiac device, health care professionals must have the capability to perform MR imaging with minimal risk and full knowledge of the possible complications." This registry recreates the protocol, safety monitoring and follow up in a manner very similar to other registries. The intent is to provide not only data that will hopefully continue to support the use of MRI scanning in device patients, but to allow this essential imaging technique to be available to patients without the need to expose them to 2 otherwise unnecessary procedures of removal and replacement of the implanted device.
This is a physician and institutional based registry that will start with New York University Langone Medical Center as collaboration between the Division of Cardiology (Electrophysiology Section) and the Department of Radiology (MRI imaging section). It is anticipated that additional sites may join in the registry over time, FDA permitting. The protocol is based on the widely published "Hopkins protocol" as attached to this submission. Several thousand patients have safely been scanned using this technique which emphasizes patient safety. Patients are monitored by experienced device personnel (ACLS certified) for vital signs (non-invasive blood pressure monitoring, pulse oximeter, and cardiac rhythm monitor (EKG)) while performing scans on patients with implanted devices. Scans are done at a major medical center equipped to manage any device or heart rhythm based complication should one occur. Only patients for whom no other imaging technique will provide adequate information are allowed to be scanned. The latter must be attested to by the physician who requires the information, and agreed upon by the electrophysiologist and the radiologist. IRB approval and a written investigator agreement will be required of any centers that may eventually participate in this registry.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MRI Scan
MRI will be performed for clinical reason for which no other imaging study will provide the data required on patients with pacemaker or implantable defibrillator
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Permanent pacemaker or ICD (single, dual or multichamber), generator implanted AFTER 2001
3. Only non-MRI Conditionally Safe pacemakers and leads (but otherwise approved by the U.S. FDA ) will be included
4. Clinical indication for MRI imaging for which no other imaging modality will give adequate results to manage the patient
5. Device must have been implanted for 6 weeks or longer
6. Patient or patient's advocate must be able and willing to provide informed consent
Exclusion Criteria
2. Presence of abandoned lead(s)
3. Presence of non-transvenous lead(s)
4. Other contra-indications to MRI scan (e.g. certain metallic implants)
5. Has an ICD, is pacemaker dependent, AND device not capable of asynchronous pacing mode
6. Battery voltage at replacement time indicator
7. Pacemaker or ICD labeled as MRI-Conditionally safe
8. Other contra-indication for MRI (e.g. morbid obesity, claustrophobia)
9. Pregnant patients
10. Systems that include lead adapters
11. Patients that have transvenous or transcutaneous temporary pacemaker
12. Leadless pacemakers
13. Other implants that are not compatible with MRI scans
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
NYU Langone Health
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IDE G150066
Identifier Type: -
Identifier Source: org_study_id